<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens
ABSTRACT Lactic acid bacteria (LAB) have been utilized since the 1990s for therapeutic heterologous gene expression. The ability of LAB to elicit an immune response against expressed foreign antigens has led to their exploration as potential mucosal vaccine candidates. LAB vaccine vectors offer many...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e43fffd460714771b64807f0e017b13e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e43fffd460714771b64807f0e017b13e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e43fffd460714771b64807f0e017b13e2021-11-15T15:24:23Z<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens10.1128/mSphere.00061-182379-5042https://doaj.org/article/e43fffd460714771b64807f0e017b13e2018-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00061-18https://doaj.org/toc/2379-5042ABSTRACT Lactic acid bacteria (LAB) have been utilized since the 1990s for therapeutic heterologous gene expression. The ability of LAB to elicit an immune response against expressed foreign antigens has led to their exploration as potential mucosal vaccine candidates. LAB vaccine vectors offer many attractive advantages: simple, noninvasive administration (usually oral or intranasal), the acceptance and stability of genetic modifications, relatively low cost, and the highest level of safety possible. Experimentation using LAB of the genus Lactobacillus has become popular in recent years due to their ability to elicit strong systemic and mucosal immune responses. This article reviews Lactobacillus vaccine constructs, including Lactobacillus species, antigen expression, model organisms, and in vivo immune responses, with a primary focus on viral and bacterial antigens.Jonathan S. LeCureuxGregg A. DeanAmerican Society for MicrobiologyarticleLactobacillusmucosal immunitymucosal vaccinesMicrobiologyQR1-502ENmSphere, Vol 3, Iss 3 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Lactobacillus mucosal immunity mucosal vaccines Microbiology QR1-502 |
spellingShingle |
Lactobacillus mucosal immunity mucosal vaccines Microbiology QR1-502 Jonathan S. LeCureux Gregg A. Dean <italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
description |
ABSTRACT Lactic acid bacteria (LAB) have been utilized since the 1990s for therapeutic heterologous gene expression. The ability of LAB to elicit an immune response against expressed foreign antigens has led to their exploration as potential mucosal vaccine candidates. LAB vaccine vectors offer many attractive advantages: simple, noninvasive administration (usually oral or intranasal), the acceptance and stability of genetic modifications, relatively low cost, and the highest level of safety possible. Experimentation using LAB of the genus Lactobacillus has become popular in recent years due to their ability to elicit strong systemic and mucosal immune responses. This article reviews Lactobacillus vaccine constructs, including Lactobacillus species, antigen expression, model organisms, and in vivo immune responses, with a primary focus on viral and bacterial antigens. |
format |
article |
author |
Jonathan S. LeCureux Gregg A. Dean |
author_facet |
Jonathan S. LeCureux Gregg A. Dean |
author_sort |
Jonathan S. LeCureux |
title |
<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
title_short |
<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
title_full |
<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
title_fullStr |
<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
title_full_unstemmed |
<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens |
title_sort |
<italic toggle="yes">lactobacillus</italic> mucosal vaccine vectors: immune responses against bacterial and viral antigens |
publisher |
American Society for Microbiology |
publishDate |
2018 |
url |
https://doaj.org/article/e43fffd460714771b64807f0e017b13e |
work_keys_str_mv |
AT jonathanslecureux italictoggleyeslactobacillusitalicmucosalvaccinevectorsimmuneresponsesagainstbacterialandviralantigens AT greggadean italictoggleyeslactobacillusitalicmucosalvaccinevectorsimmuneresponsesagainstbacterialandviralantigens |
_version_ |
1718427981938950144 |